[Jaundices of therapeutic origin].
D000970:Antineoplastic Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D001152:Arsenicals / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications*; D002746:Chlorpromazine / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000150:complications*; D006221:Halothane / Q000009:adverse effects; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007049:Iatrogenic Disease; D007565:Jaundice / Q000209:etiology*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects
D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D001152:Arsenicals; D003276:Contraceptives, Oral; D007004:Hypoglycemic Agents; D008996:Monoamine Oxidase Inhibitors; D002746:Chlorpromazine; D006221:Halothane
Gli itteri di origine terapeutica.